Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age-Reference-Cited by-同舟云学术

Immunogenicity and Safety of AS03-adjuvanted H5N1 Influenza Vaccine in Children 6–35 Months of Age

Published:2021-07-19 Issue:9 Volume:40 Page:e333-e339
ISSN:0891-3668
Container-title:Pediatric Infectious Disease Journal
language:en
Short-container-title:

Author:

Kim Joon Hyung,Drame Mamadou,Puthanakit Thanyawee,Chiu Nan-Chang,Supparatpinyo Khuanchai,Huang Li-Min,Chiu Cheng-Hsun,Chen Po-Yen,Hwang Kao-Pin,Danier Jasur,Friel Damien,Salaun Bruno,Woo Wayne,Vaughn David W.,Innis Bruce,Schuind Anne

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Microbiology (medical),Pediatrics, Perinatology, and Child Health

Reference14 articles.

1. Avian influenza a virus pandemic preparedness and vaccine development.;de Vries;Vaccines (Basel),2018

2. Immunogenicity and tolerability of an AS03(A)-adjuvanted prepandemic influenza vaccine: a phase III study in a large population of Asian adults.;Chu;Vaccine,2009

3. Immunogenicity and Safety of H5N1 A/Vietnam/1194/2004 (Clade 1) AS03-adjuvanted prepandemic candidate influenza vaccines in children aged 3 to 9 years: a phase II, randomized, open, controlled study.;Díez-Domingo;Pediatr Infect Dis J,2010

4. AS03B-adjuvanted H5N1 influenza vaccine in children 6 months through 17 years of age: a phase 2/3 randomized, placebo-controlled, observer-blinded trial.;Kosalaraksa;J Infect Dis,2015

5. Safety and cross-reactive immunogenicity of candidate AS03-adjuvanted prepandemic H5N1 influenza vaccines: a randomized controlled phase ½ trial in adults.;Langley;J Infect Dis,2010

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recommendations for Prevention and Control of Influenza in Children, 2024–2025: Technical Report;Pediatrics;2024-08-26

2. A Bioinformatics Study of the Influenza H5N1 Virus that Infects Wild Fowl and Poultry and, Potentially, Humans;Current Analytical Chemistry;2023-12

3. Recommendations for Prevention and Control of Influenza in Children, 2023–2024;Pediatrics;2023-08-29

4. Robust induction of functional humoral response by a plant-derived Coronavirus-like particle vaccine candidate for COVID-19;npj Vaccines;2023-02-13

5. Recommendations for Prevention and Control of Influenza in Children, 2022–2023;Pediatrics;2022-09-06